Rapamycin (mTORC1 inhibitor) reduces the production of lactate and 2-hydroxyglutarate oncometabolites in IDH1 mutant fibrosarcoma cells

BACKGROUND: Multiple studies concluded that oncometabolites (e.g. D-2-hydroxyglutarate (2-HG) related to mutant isocitrate dehydrogenase 1/2 (IDH1/2) and lactate) have tumour promoting potential. Regulatory mechanisms implicated in the maintenance of oncometabolite production have great interest. mT...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Exp Clin Cancer Res
Main Authors: Hujber, Zoltán, Petővári, Gábor, Szoboszlai, Norbert, Dankó, Titanilla, Nagy, Noémi, Kriston, Csilla, Krencz, Ildikó, Paku, Sándor, Ozohanics, Olivér, Drahos, László, Jeney, András, Sebestyén, Anna
Format: Artigo
Sprog:Inglês
Udgivet: BioMed Central 2017
Fag:
Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5457553/
https://ncbi.nlm.nih.gov/pubmed/28578659
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13046-017-0544-y
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker